{"id":"W4415941235","doi":"10.1016/j.annonc.2025.08.2591","title":"1967P MET testing and treatment (tx) sequencing after progression on first-line (1L) osimertinib (osi) in patients (pts) with EGFRm advanced NSCLC and acquired MET overexpression and/or amplification (OverExp/Amp): interim analysis of a global real-world (rw) study","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Osimertinib; Interim analysis; Interim; C-Met; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001788826,0.0008472512,0.0009331039,0.000330885,0.0002402708,0.001012904,0.0004719521,0.0006266431,0.001161775],"category_scores_gemma":[0.001513445,0.0003821762,0.001487384,0.0006177606,0.0004225661,0.0009744894,0.0005357009,0.001206739,0.0003115729],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004117994,"about_ca_system_score_gemma":0.0005399105,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008519897,"about_ca_topic_score_gemma":0.002230231,"domain_scores_codex":[0.9993989,0.0002561048,0.00002494342,0.0001419441,0.00006585551,0.0001121677],"domain_scores_gemma":[0.9988249,0.0002321077,0.0004195051,0.0002041687,0.00007553976,0.0002439016],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1489917,0.001786052,0.7753611,0.0002650067,0.004844721,0.0004376232,0.000273632,0.005575541,0.007171573,0.0002435196,0.003190979,0.05185863],"study_design_scores_gemma":[0.006589675,0.02591839,0.9544287,0.00004659594,0.003551185,0.0006950396,0.0002229186,0.002644831,0.002391609,0.0004373622,0.003019058,0.00005461011],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971164,0.0002939592,0.0002493032,0.00006573738,0.00001593095,0.00003959897,0.001616028,0.00002007463,0.0005829125],"genre_scores_gemma":[0.9922644,0.0001659983,0.0003972224,0.0001637322,0.00002745197,0.00006438979,0.006350019,0.00001635348,0.0005504827],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001788826,"threshold_uncertainty_score":0.00946033,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07704972867911013,"score_gpt":0.4562838769249002,"score_spread":0.37923414824579,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}